End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
48.65 TWD | +1.99% |
|
-1.12% | -21.91% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- The company is in debt and has limited leeway for investment
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.14 times its estimated earnings per share for the ongoing year.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-21.91% | 8.75B | B+ | ||
-3.57% | 37.21B | B- | ||
-26.35% | 20.28B | B- | ||
-26.89% | 11.33B | B- | ||
+4.25% | 11.3B | A- | ||
+27.47% | 8.81B | C+ | ||
-12.15% | 5.47B | C+ | ||
-46.00% | 4.09B | C | ||
-29.31% | 3.35B | B+ | ||
-34.05% | 2.68B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 1326 Stock
- Ratings Formosa Chemicals & Fibre Corporation